-Bloomberg
-Bloomberg
Ascendis Pharma’s Growth Hormone Deficiency Med Scores European Approval
The European Commission (EC) has granted marketing authorization to Ascendis Pharma A/S's (NASD
US Seeks $4.3B To Buy Enriched Uranium From Domestic Sources
-Bloomberg-Bloomberg
Related Posts
Apple Joins Cost Cut Bandwagon, Eases On Bonus, Hiring, Triggers Employee Fears Of Layoffs
Apple Inc (NASDAQ: AAPL) is postponing perks for some corporate divisions and expanding a cost-cutting effort joining its peers in streamlining operations amid business slowdown and economic uncertainties.
Why Did Fresenius Medical Care Shares Plunge To 52-Week Low
Shares of kidney dialysis provider Fresenius Medical Care AG & Co (NYSE:FMS) touched a 52-week low after the company cut its…
Truist Securities Upgrades PacWest Banc to Buy, Announces $50 Price Target
Truist Securities analyst Brandon King upgrades PacWest Banc (NASDAQ:PACW) from Hold to Buy and announces $50 price target.